BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12402162)

  • 1. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
    Osame M
    J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nakamura T
    Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
    Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
    Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
    Best I; López G; Verdonck K; González E; Tipismana M; Gotuzzo E; Vanham G; Clark D
    Immunology; 2009 Sep; 128(1 Suppl):e777-86. PubMed ID: 19740339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
    Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
    Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
    Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
    Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
    J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Matsuura E; Kubota R; Tanaka Y; Takashima H; Izumo S
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):2-14. PubMed ID: 25470342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease.
    Sabouri AH; Usuku K; Hayashi D; Izumo S; Ohara Y; Osame M; Saito M
    Blood; 2008 Sep; 112(6):2411-20. PubMed ID: 18502825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TSLC1 in patients with HAM/TSP.
    Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
    J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology.
    Izumo S
    Neuropathology; 2010 Oct; 30(5):480-5. PubMed ID: 20573027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.